Skip to content
Study at Cambridge
About the University
Research at Cambridge
Services
Connecting Cambridge Innovation
Academic Consultancy Services
Pioneering Research Innovations
Venture Building & Investment
About
Our team
Our performance
Careers
The Cambridge Ecosystem
Beyond the University
Partnerships and collaboration
FAQs
Stories & Events
News
Events
Insights
Case Studies
Videos
Contact
Search
Menu
Archive
Posts Tagged ‘Morphogen-ix’
Case Studies
Centessa Pharmaceuticals: Three portfolio companies merge into a new pharmaceutical giant
16 February 2022
News
2021 Annual Review reports success for Cambridge Enterprise
27 January 2022
News
Three Cambridge spin-outs join Centessa Pharmaceuticals, launched today with a $250m Series A round
16 February 2021
News
Spin-out Morphogen-IX raises £18.4m in a Series B financing
18 December 2018
News
Spin-out Morphogen-IX announces its clinical development candidate
27 November 2018
News
Spin-out Morphogen-IX announces appointment of CEO and SAB members
28 June 2018
Case Studies
New potential treatment for pulmonary arterial hypertension
23 May 2016
News
Morphogen-IX gains funding to develop treatment for pulmonary arterial hypertension
18 January 2016
1-8 of 8
Previous page
Next page
Page
1
1
of 1